motesanib diphosphate

DRUG3 trials

Sponsors

Amgen, Jonsson Comprehensive Cancer Center, Gynecologic Oncology Group

Conditions

Fallopian Tube CancerLung CancerLymphomaLymphoproliferative DisorderNon-Small Cell Lung CancerOvarian CancerPrimary Peritoneal Cavity CancerUnspecified Adult Solid Tumor, Protocol Specific

Phase 1

Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

CompletedNCT00094835

AmgenLung Cancer, Non-Small Cell Lung Cancer

Start: 2005-01-31End: 2007-03-31Updated: 2016-03-24

AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma

Jonsson Comprehensive Cancer CenterLung Cancer, Lymphoma, Lymphoproliferative Disorder +1

Start: 2005-10-31Target: 18Updated: 2013-09-17

Phase 2

AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

TerminatedNCT00574951

Gynecologic Oncology GroupFallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer

Start: 2007-12-31Updated: 2018-01-11